Sign in
4

Changes in Ownership

Emmaus Life Sciences, Inc. Filed Acc 0001209191-20-046906

Chairman and CEO bought 1,600 shares at an average $1.50 ($2,401)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Niihara Yutaka Chairman and CEO 2020-08-13 Purchase +1,100 $1.46 $1,606 10,675,646 D
Niihara Yutaka Chairman and CEO 2020-08-14 Purchase +500 $1.59 $795 10,676,146 D
Open-market purchases · 1,600 sh · avg $1.50 · $2,401
Loading xslF345X03/doc4.xml…